- Experience and expertise. Mayo Clinic specialists diagnose and treat many inherited conditions, such as Lynch syndrome and other familial cancer syndromes. Mayo surgeons have built one of the largest and most experienced minimally invasive surgery practices in the United States.
- Teamwork. At Mayo Clinic, a team of experts in gastroenterology, oncology, colon and rectal surgery, and medical genetics, and other experts if needed, create a customized treatment plan for you.
- Advanced technologies. Mayo specialists use advanced screening and diagnostic methods, including tumor and genetic testing, to help detect gene mutations long before cancer occurs. Mayo Clinic developed a screening procedure to detect microsatellite instability (MSI) for people with newly diagnosed colorectal cancer. MSI screening helps determine who may need testing for Lynch syndrome, ensuring appropriate evaluation, treatment and genetic counseling. In addition, Mayo operates a large state-of-the-art colon cancer treatment and prevention center.
- Comprehensive cancer center. Mayo Clinic Cancer Center meets strict standards for a National Cancer Institute comprehensive cancer center, which recognizes scientific excellence and a multispecialty approach focused on cancer prevention, diagnosis and treatment.
Mayo Clinic in Rochester, Minn., ranks No. 1 for digestive disorders in the U.S. News & World Report Best Hospitals rankings. Mayo Clinic in Scottsdale, Ariz., and Mayo Clinic in Jacksonville, Fla., are ranked high performing for digestive disorders by U.S. News & World Report.
Mayo Clinic: Answers you can trust
At Mayo Clinic, we assemble a team of specialists who take the time to listen and thoroughly understand your health issues and concerns. We tailor the care you receive to your personal health care needs. You can trust our specialists to collaborate and offer you the best possible outcomes, safety and service.
Mayo Clinic is a not-for-profit medical institution that reinvests all earnings into improving medical practice, research and education. We're constantly involved in innovation and medical research, finding solutions to improve your care and quality of life. Your doctor or someone on your medical team is likely involved in research related to your condition.
Our patients tell us that the quality of their interactions, our attention to detail and the efficiency of their visits mean health care — and trusted answers — like they've never experienced.
Why Choose Mayo Clinic
What Sets Mayo Clinic Apart
Mar. 10, 2012
- Genetics of colorectal cancer (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/genetics/colorectal/healthprofessional. Accessed Jan. 24, 2012.
- Lindor NM, et al. Concise handbook of familial cancer susceptibility syndromes. Journal of the National Cancer Institute Monographs. 2008;38:1.
- Colorectal cancer screening. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Jan. 31, 2012.
- Lindor NM, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review. Journal of the American Medical Association. 2006;296:1507.
- Abeloff MD, et al. Abeloff's Clinical Oncology. 4th ed. Philadelphia, Pa.: Churchill Livingstone; 2008:180.
- Backes FJ, et al. Lynch syndrome. Clinical Obstetrics and Gynecology. 2011;54:199.
- Making sense of your genes: A guide to genetic counseling. National Society of Genetic Counselors. http://www.nsgc.org/client_files/GuidetoGeneticCounseling.pdf. Accessed Jan. 24, 2012.
- Kaltenbach T, et al. Image-enhanced endoscopy is critical in the detection, diagnosis and treatment of non-polypoid colorectal neoplasms. Gastrointestinal Endoscopy Clinics of North America. 2010;20:471.
- Pande M, et al. Smoking and colorectal cancer in Lynch syndrome: Results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. 2010;16:1331.
- Burn J, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. Lancet. 2011;378:2081.